Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Gordon

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 26, 2026
Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 YearsMônica R Gadelha, Murray B Gordon, Mirjana Doknic, et al.
Frontiers in Endocrinology|April 1, 2021
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor LigandsMaria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Frontiers in Endocrinology|August 2, 2021
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Frontiers in Endocrinology|May 16, 2022
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Clinical Diabetes and Endocrinology|December 9, 2020
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendationsDavid R Brown, Honey E East, Bradley S Eilerman, et al.
Pituitary|July 19, 2012
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adultsKevin C J Yuen, Beverly M K Biller, Laurence Katznelson, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 24, 2020
Growth hormone replacement in adults: Real-world data from two large studies in US and EuropeMatthias M Weber, Murray B Gordon, Charlotte Höybye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 13, 2012
Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormoneSreevidya K Subbarayan, Maria Fleseriu, Murray B Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With AcromegalyMonica R Gadelha, Murray B Gordon, Mirjana Doknic, et al.
Journal of the Endocrine Society|July 7, 2025
Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus PanelSusan L Samson, Diane Donegan, Eliza B Geer, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|June 26, 2026
Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 YearsMônica R Gadelha, Murray B Gordon, Mirjana Doknic, et al.
Frontiers in Endocrinology|April 1, 2021
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor LigandsMaria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Frontiers in Endocrinology|August 2, 2021
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Frontiers in Endocrinology|May 16, 2022
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Clinical Diabetes and Endocrinology|December 9, 2020
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendationsDavid R Brown, Honey E East, Bradley S Eilerman, et al.
Pituitary|July 19, 2012
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adultsKevin C J Yuen, Beverly M K Biller, Laurence Katznelson, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 24, 2020
Growth hormone replacement in adults: Real-world data from two large studies in US and EuropeMatthias M Weber, Murray B Gordon, Charlotte Höybye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 13, 2012
Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormoneSreevidya K Subbarayan, Maria Fleseriu, Murray B Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With AcromegalyMonica R Gadelha, Murray B Gordon, Mirjana Doknic, et al.
Journal of the Endocrine Society|July 7, 2025
Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus PanelSusan L Samson, Diane Donegan, Eliza B Geer, et al.
Pageof 4